MOTS-c
Also known as: Mitochondrial ORF of the 12S rRNA type-c, Mitochondrial-derived peptide, MDP
MOTS-c is a mitochondrial-derived peptide that regulates cellular metabolism and glucose homeostasis. This 16-amino acid peptide enhances insulin sensitivity, promotes fat oxidation, and may extend healthspan through mitochondrial optimization.
MOTS-c is a 2174.5 Da research peptide. MOTS-c is a mitochondrial-derived peptide that regulates cellular metabolism and glucose homeostasis. This 16-amino acid peptide enhances insulin sensitivity, promotes fat oxidation, and may extend healthspan through mitochondrial optimization.
Also called: Mitochondrial ORF of the 12S rRNA type-c, Mitochondrial-derived peptide, MDP
2174.5
Molecular Weight
Daltons
2
Strong Evidence
benefits
3
Studies Cited
peer-reviewed
5-10
Typical Dose
mg
Overview
MOTS-c represents a novel class of mitochondrial-derived peptides encoded by the mitochondrial genome rather than nuclear DNA. This bioactive peptide functions as a metabolic regulator, primarily targeting skeletal muscle and liver tissues to enhance glucose uptake and fatty acid oxidation. MOTS-c activates AMPK (AMP-activated protein kinase) pathways, which serve as cellular energy sensors. When cellular energy stores are low, AMPK activation promotes glucose uptake, fatty acid oxidation, and mitochondrial biogenesis. The peptide also influences gene expression related to metabolic homeostasis and cellular stress resistance. Research indicates MOTS-c levels decline with age, making it a target for metabolic dysfunction and age-related decline. Unlike traditional peptides, MOTS-c can cross cellular membranes and directly influence nuclear gene expression, creating a unique mitochondrial-nuclear communication pathway. This mechanism positions MOTS-c as both a metabolic enhancer and potential longevity intervention.
Key Takeaways: MOTS-c
- Strongest evidence supports MOTS-c for enhanced insulin sensitivity and increased fat oxidation
- Research doses typically range from 5 to 10 mg via subcutaneous
- 2 benefits with strong evidence, 2 moderate, 2 preliminary
- Half-life: 2-4 hours (subcutaneous)
- 3 cited research studies in this guide
Mechanism of Action
MOTS-c activates AMPK signaling pathways in skeletal muscle and liver tissue, promoting glucose uptake and fatty acid oxidation. The peptide translocates to the nucleus where it regulates gene expression of metabolic enzymes and mitochondrial biogenesis factors. MOTS-c also enhances insulin sensitivity by improving glucose transporter translocation and reducing inflammatory cytokine production in adipose tissue.
Research Benefits
MOTS-c at a Glance
MOTS-c activates AMPK signaling pathways in skeletal muscle and liver tissue, promoting glucose uptake and fatty acid oxidation.
Enhanced Insulin Sensitivity
Strong EvidenceMOTS-c improves glucose uptake in skeletal muscle by 30-40% through GLUT4 transporter activation and AMPK phosphorylation, reducing blood glucose levels and enhancing metabolic flexibility.
Increased Fat Oxidation
Strong EvidenceThe peptide upregulates carnitine palmitoyltransferase I (CPT1) expression, increasing fatty acid oxidation by 25-35% and promoting the shift from glucose to fat as primary fuel source.
Mitochondrial Biogenesis
Moderate EvidenceMOTS-c stimulates PGC-1α expression, triggering new mitochondrial formation and improving cellular energy production capacity by enhancing oxidative phosphorylation efficiency.
Exercise Performance Enhancement
Moderate EvidenceResearch shows MOTS-c supplementation increases endurance capacity by 20-30% through improved mitochondrial function and enhanced lactate clearance during high-intensity exercise.
Age-Related Metabolic Decline Prevention
PreliminaryThe peptide reverses age-associated decline in glucose tolerance and muscle insulin sensitivity, potentially extending metabolic healthspan through preserved mitochondrial function.
Neuroprotective Effects
PreliminaryMOTS-c crosses the blood-brain barrier and enhances neuronal mitochondrial function, showing potential for protecting against age-related cognitive decline and neurodegenerative processes.
Research Dosing Protocols
Research Purposes Only: All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.
| Research Protocol | Dose Range | Route |
|---|---|---|
| Metabolic enhancement | 5–10 mg | subcutaneous |
| Exercise performance | 10–15 mg | subcutaneous |
| Anti-aging research | 5–10 mg | subcutaneous |
Frequency
3 times per week
Timing
30-60 minutes before meals or exercise
Cycle Length
8-12 weeks with 4-week breaks
Research Notes
- 1Start with lower doses to assess tolerance
- 2Effects typically noticed within 2-3 weeks
- 3Best results when combined with exercise protocols
- 4Consider glucose monitoring during initial weeks
Reconstitution Guide
Standard Reconstitution
Vial Size
5 mg
Bacteriostatic Water
1 mL
Concentration
50 mcg
per 0.1 mL (10 units)
Step-by-Step Guide
Gather Materials
MOTS-c vial, bacteriostatic water, alcohol swabs, insulin syringes.
Equilibrate Temperature
Remove the vial from storage and allow it to reach room temperature (5-10 minutes).
Sanitize
Swab the rubber stopper of both the peptide vial and bacteriostatic water vial with alcohol.
Draw Water
Draw 1 mL of bacteriostatic water into a syringe.
Add Water to Vial
Insert the needle into the peptide vial and direct the water stream against the glass wall — not directly onto the powder.
Mix Gently
Swirl the vial gently until the powder is fully dissolved. Never shake. The solution should be clear and colorless.
Store Properly
Refrigerate at 2-8°C (refrigerated). 30 days when reconstituted.
Storage Temperature
2-8°C (refrigerated)
Shelf Life
30 days when reconstituted
Important Notes
- •Use bacteriostatic water for multi-dose vials
- •Gently swirl, never shake vigorously
- •Protect from light during storage
- •Draw with insulin syringes for accuracy
MOTS-c Dosing Calculator
Calculate daily intake, cycle totals, and vials needed with pre-filled protocols →
MOTS-c Reconstitution Calculator
Calculate concentration, syringe units, and doses per vial with auto-filled values →
Safety & Side Effects
Reported Side Effects
- !Mild injection site reactions (redness, swelling)
- !Transient hypoglycemia in sensitive individuals
- !Gastrointestinal upset (nausea, bloating)
- !Initial fatigue as metabolism adjusts
- !Headaches during first week of use
- !Sleep disturbances if injected late evening
- !Increased appetite during adaptation phase
- !Muscle cramps from enhanced glucose uptake
Potential Interactions
- ⚡Diabetes medications - may enhance hypoglycemic effects
- ⚡Metformin - additive AMPK activation effects
- ⚡Beta-blockers - may blunt metabolic responses
- ⚡Thyroid hormones - potential additive metabolic effects
Important: Side effects and interactions listed here are compiled from published research and community reports. This is not a complete list. No formal drug interaction studies have been conducted for most research peptides. Always consult a qualified healthcare provider.
Research Studies
The following studies are referenced in this profile. PubMed IDs are provided where available for independent verification.
A mitochondrial-derived peptide reduces adiposity and increases muscle mass and function
MOTS-c treatment improved insulin sensitivity, reduced weight gain, and enhanced muscle function in diet-induced obesity models through AMPK activation.
MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline
Exercise increases MOTS-c levels, and supplementation restored age-related decline in physical performance and glucose homeostasis in aged mice.
Mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis via skeletal muscle
MOTS-c levels correlate with metabolic health markers in humans, with lower levels associated with insulin resistance and metabolic syndrome.
Note: This is not an exhaustive list of all published research. Studies are selected for relevance and quality. Click PubMed IDs to verify sources independently. Inclusion does not imply endorsement of the peptide for any clinical use.
Frequently Asked Questions
Most researchers report initial metabolic improvements within 2-3 weeks, with peak effects on glucose sensitivity and fat oxidation appearing after 4-6 weeks of consistent administration.
No, MOTS-c must be administered via injection as oral bioavailability is extremely poor due to peptide degradation in the digestive system. Subcutaneous injection is the standard route.
Research protocols typically use 8-12 week cycles followed by 4-week breaks to prevent potential receptor downregulation, though long-term safety data remains limited.
Unlike synthetic peptides, MOTS-c is naturally encoded by mitochondrial DNA and specifically targets AMPK pathways. It focuses on metabolic flexibility rather than just weight loss like some other compounds.
MOTS-c can enhance glucose uptake, potentially causing low blood sugar in predisposed individuals or those taking diabetes medications. Blood glucose monitoring is recommended during initial weeks.
Long-term safety data is limited as MOTS-c research is relatively recent. Current studies show good short-term tolerance, but extended use requires careful monitoring and medical oversight.
Yes, exercise naturally increases endogenous MOTS-c production and enhances the peptide's metabolic effects. Combining supplementation with regular exercise appears to optimize results.
Most research uses morning or pre-workout timing to align with natural metabolic rhythms. Avoid evening injections as enhanced metabolism may interfere with sleep quality.
Research & Educational Use Only
All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.
The information presented here is compiled from published research studies and is intended for informational purposes only. Individual results may vary. Always consult with a licensed healthcare provider.